Biomarkers for predicting the efficacy of bevacizumab treatment
Posted in the Colon Cancer Forum
#1 Aug 1, 2011
A US patent application from Hoffman-La Roche describes the use of VEGFA, HER2 and neuropilin as biomarkers for perdicitng the efficacy of bevacizumab treatment in colorectal cancer patients. News link: http://www.sciclips.com/sciclips/biomarker-ne...
Add your comments below
|The 10 commandments of cancer prevention (May '09)||Dec 1||Trying to be hopeful||36|
|When to give up: Treatment or comfort for late-... (Jun '16)||Jun '16||betty||2|
|can viagra make you go deaf? (Apr '16)||Apr '16||Wyatt||1|
|viagra's hidden uses: diet pill, cancer fighter? (Mar '16)||Mar '16||Howard||1|
|Testing, knowledge key to detecting colon cancer (Mar '16)||Mar '16||huey goins||2|
|WGRZ News - Colon Cancer: One Man's Fight (Mar '08)||Jan '16||chris||15|
|Namber Of Plyps (Dec '15)||Dec '15||Amy||2|
Find what you want!
Search Colon Cancer Forum Now
Copyright © 2016 Topix LLC